Transglutaminase 2 (TG2) is a ubiquitous enzyme with transamidating activity. We 35 report here that the expression and activity of TG2 are enhanced in cells infected with the 36 obligate intracellular bacteria Chlamydia trachomatis. Genetic or pharmacological inhibition 37 of TG2 activity impair bacterial development. We show that TG2 increases glucose import by 38 up-regulating the transcription of the glucose transporter genes GLUT-1 and GLUT-3. 39 Furthermore, TG2 activation drives one specific glucose-dependent pathway in the host, i.e. 40 hexosamine biosynthesis. Mechanistically, we identify the glucosamine:fructose-6-phosphate 41 amidotransferase (GFPT) among the substrates of TG2. GFPT modification by TG2 increases 42 its enzymatic activity, resulting in higher levels of UDP-N-acetylglucosamine biosynthesis. As 43 a consequence, TG2 activation results in increased protein O-GlcNAcylation. The correlation 44 between TG2 transamidating activity and O-GlcNAcylation is disrupted in infected cells 45 because host hexosamine biosynthesis is being exploited by the bacteria, in particular to assist 46 their division. In conclusion, our work establishes TG2 as a key player in controlling glucose-47 derived metabolic pathways in mammalian cells, themselves hijacked by C. trachomatis to 48 sustain their own metabolic needs. 49 50 51 KEYWORDS: Chlamydia / GFPT / Hexosamine biosynthesis / O- GlcNAcylation /  52  Transglutaminase 2  53  54  55  INTRODUCTION  56  57 The enzyme transglutaminase 2 (TG2) is an extremely versatile protein exhibiting 58 transamidase, protein disulfide isomerase and guanine and adenine nucleotide binding and 59 hydrolyzing activities (Gundemir, Colak et al., 2012) . Also designated as "tissue 60 transglutaminase", it is ubiquitously expressed in the cytoplasm and at the cell surface in 61 association with the extracellular matrix (Eckert, Kaartinen et al., 2014) . The transamidase 62 activity is the best described activity, and it is regulated by Ca 2+ (Gundemir et al., 2012) . It 63 results in the formation of cross-links between proteins, or of post-translational modification 64 of a protein substrate through incorporation of a small primary amine, or deamidation of a 65 glutamine into a glutamate. Under steady-state conditions, TG2 exists in a compact, inactive 66 conformation. Increase in intracellular Ca 2+ concentration (upon stress, cell activation, etc) 67 causes a conformational change, and the enzyme becomes catalytically active as a 68
transamidase. Studies of genetically engineered mouse models and/or inherited disorders 69 have implicated TG2 in several pathological conditions (Iismaa, Mearns et al., 2009 ). In 70 particular, increased TG2 expression and transamidation activity is a common feature of many 71 inflammatory diseases and events (Eckert et al., 2014) . Possibly linked to its increased 72 expression in inflammatory processes, several lines of evidence suggest the involvement of 73 TG2 during cancer development (Huang, Xu et al., 2015) . 74 Surprisingly, while the association between TG2 activity and inflammatory situations has 75 been studied in several normal and pathological situations (Di Sabatino implication of this enzyme in a very classical inflammatory process, e.g. the defense response 78 of a tissue to the invasion by a microorganism, has remained very poorly investigated. 79
Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen, and it 80 develops inside a vacuole in a human host cell, typically an epithelial cell of the genital tract 81 (reviewed in (AbdelRahman & Belland, 2005) ). This obligate intracellular bacterium depends 82 on the host to supply several essential metabolites, and in particular glucose (Gehre, Gorgette 83 et al., 2016, Stephens, Kalman et al., 1998) . Epithelial cells respond to the infection with the 84 secretion of proinflammatory cytokines such as IL-6 and IL-8 (Rasmussen, Eckmann et al., 85 1997) . The inflammatory response is exacerbated upon reinfection, ultimately leading to 86 tissue damage such as hydrosalpinx and fibrosis (Brunham & Rey-Ladino, 2005) . In this work, 87
we show that TG2 becomes activated during the infection of epithelial cells with C. 88 trachomatis, and is required for optimal bacterial growth. incorporation was the result of to the transamidase activity of TG2 ( Fig. 1A ). Live proliferating 110 bacteria were needed for TG2 activation since filtered or heat-inactivated bacteria, or bacteria 111 treated with the antibiotic doxycycline immediately after infection to prevent their 112 proliferation, failed to induce BP incorporation ( Fig. 1B and Fig. S1 ). BP incorporation upon 113
infection was also observed in wild type mouse embryonic fibroblasts (MEFs) but not in MEFs 114 isolated from tgm2 knocked-out animals (TG2 -/-), further supporting the implication of TG2 in 115 this process (Fig. 1C ). 116
Probing cellular lysates using anti-TG2 antibodies showed that activation of TG2 was 117 accompanied with an increased expression of the enzyme (Fig. 1D ). Consistent with this 118 observation, inhibition of protein synthesis with cycloheximide decreased infection-induced 119 BP incorporation ( Fig. 1B ). Reverse transcription followed by quantitative PCR (RT-qPCR) 120 measurements revealed a 3-to 4-fold increase in TG2 transcripts in infected versus non-121 infected cells, demonstrating that the increase in TG2 amount during infection is at least partly 122 controlled at the transcriptional level ( Fig. 1E ). Interestingly, a positive feedback loop controls 123 TG2 expression since TG2 transcription was no longer enhanced by infection when cells were 124 treated with CP4d ( Fig. 1E ). 125
In conclusion, C. trachomatis infection increases TG2 levels and activates its 126 transamidase activity. 127 128 TG2 activity sustains bacterial growth 129
To determine if TG2 activity affected bacterial development, we infected HeLa cells in 130 the presence or not of the transamidase inhibitor CP4d. Thirty h later, the progeny was 131 collected and the number of infectious bacteria was determined by infecting fresh cells. 132
Inhibition of TG2 activity with 40 µM CP4d resulted in a 2-fold decrease in bacterial progeny 133 ( Fig. 2A ). Consistently, a similar reduction in bacterial progeny was observed when bacteria 134
were grown on TG2 -/-MEFs compared to TG2 +/+ (Fig. S2A ). To confirm these findings in primary 135 cells, we used epithelial cells isolated from fallopian tubes (Roth, Konig et al., 2010) . CP4d was 136 even more potent at reducing the progeny after one developmental cycle in these cells than 137 in HeLa cells, as a ten-fold reduction was observed for 10 µM CP4d (Fig. 2B ) . The negative  138  impact of TG2 inhibition on bacterial development was also observed in primary cells infected  139 with C. trachomatis serovar D, showing that the effect is not restricted to the LGV biovar ( Fig.  140 2B). 141
Reduced progeny could result from impairment of one or several of the steps of the 142 chlamydial developmental cycle: adhesion, entry, differentiation into the replicative form, 143 proliferation, and differentiation into the infectious form. We observed that inhibition of TG2 144 had no effect on bacterial adhesion ( Fig. S2B ), but that 40 µM CP4d decreased the percentage 145 of infected cells by about 2-fold in HeLa cells ( Fig. 2C ), consistent with a lower internalization 146 efficiency ( Fig. S2C ). In addition, inclusions were smaller in cells treated with CP4d, and 147 contained less bacteria, indicating that bacterial growth was slower in the absence of TG2 148 activity (Fig. 2C ). The reduction of inclusion size when TG2 was inhibited was also observed in 149 primary cells infected with C. trachomatis L2 or serovar D ( Fig. 2D ). 150
We next tested the incidence of the absence of TG2 on chlamydial development in a 151 mouse model of infection. Chlamydia muridarum is a mouse-adapted strain genetically very 152 close to C. trachomatis (Read, Brunham et al., 2000) , and infection of HeLa cells with C. 153 muridarum also activated TG2 ( Fig. S3 ). We infected TG2 +/+ and TG2 -/mice intravaginally with 154
C. muridarum and 25 days after infection, mice were sacrificed and the genital tract was 155 isolated ( Fig. 2E ). DNA was extracted from the upper genital tract and bacterial load was 156 determined by qPCR. A slightly higher number of mice retained detectable bacterial DNA in 157 the wild type group (10/16, 62 %, for the TG2 +/+ and 4/9, 44% for the TG2 -/mice). Among the 158 animals in which bacterial DNA was still detected, the trend was for a higher bacterial load in 159 the wild type background, but the number of TG2 -/animals we could breed was too low for 160 statistical significance. These data indicate that the absence of TG2 reduces only marginally, 161
if at all, the ability for C. muridarum to establish an infection. It is however possible that in 162 some tissues the loss of TG2 is compensated by expression of other transgluatminases, 163
limiting the interpretation of these data (Iismaa et al., 2009). One clear difference between 164 the two groups came from anatomical observations: TG2 -/animals showed milder signs of 165 inflammation than their wild type littermate, especially when the oviduct hydrosalpinx scores 166 were compared. However, it appears that the presence of TG2 exacerbates the tissue damage 167 in this mouse model of infection, in line with the implication of TG2 in tissue fibrosis ( this hypothesis was correct, one prediction that we could make was that low glucose 178 availability in the culture medium should be more detrimental to bacterial growth in TG2 -/-179 MEFs compared to the wild type MEFs, as TG2 -/-MEFs would be impaired in their ability to 180 adjust their glucose uptake to sustain bacterial growth. To test this hypothesis, we grew MEFs 181 in medium containing decreasing concentrations of glucose and measured the number of 182 infectious bacteria collected 30 hpi. As expected we observed that decreasing glucose 183 availability resulted in a sharp decrease in bacterial titers, in both cellular backgrounds. 184
However, bacterial titers were more sensitive to glucose deprivation in the TG2 -/-MEFs than 185 in the wild-type cells (Fig. 3A ). For instance, at 1 mg/mL glucose, the progeny was reduced by 186 82% in the TG2 -/-MEFs, compared to only 35% in the TG2 +/+ MEFs. 187
To test the implication of TG2 in the rewiring of host metabolism more directly, we 188 measured the incidence of TG2 inactivation on the cell capacity to uptake glucose. HeLa cells 189 infected with C. trachomatis show increased transcription of GLUT-1 and GLUT-3, which allows 190 to increase glucose uptake and meet bacterial needs (Wang et al., 2017). We reproduced this 191 result in HeLa cells, as well as in primary cells isolated from the endocervix (Fig. 3B ). In 192 contrast, in the presence of the TG2 inhibitor CP4d, the transcription of the glucose 193
transporter genes was no longer induced by infection, indicating that TG2 is necessary for the 194 control of GLUT-1 and GLUT-3 transcription. Absence of increase in GLUT-1 and GLUT-3 195 transcripts 48 hpi in the presence of CP4d was not due to the lower bacterial burden because 196 when bacterial proliferation was interrupted 24 hpi by addition of doxycycline we observed a 197 comparable reduction in bacterial load at 48 hpi as in cells treated with CP4d, but the 198 transcription of the glucose transporter genes remained as high as in non-treated cells (Fig. 199 S4). 200
Finally, to explore further the incidence of TG2 expression on that of glucose 201 transporters we examined transcriptional data from a cohort of high grade serous ovarian 202 cancer (HGSOC) patients. This population was chosen because clinical and biological data 203 indicate that TG2 overexpression is an adverse prognostic factor in ovarian carcinoma (Hwang, 204 Mangala et al., 2008, Shao, Cao et al., 2009). We observed a significant correlation between 205 expression of TGM2 and GLUT-3 across the 265 clinical HGSOC specimens (ρ=0.50, P<0.001) 206
( Fig.3C) . The HGSOC cohort also demonstrated significant correlation between TG2 and GLUT-207 1 expression, though the magnitude of correlation was less marked (ρ=0.21, P<0.001) ( Fig.  208 3C). Collectively, these data support the notion that TG2 plays a central role in regulating 209 glucose transporters expression regulation in the context of infection or malignancy, thereby 210 playing a central role in the control of the metabolic balance. 211 212 TG2 targets glutamine:fructose-6-P amidotransferase and enhances its activity 213
In addition to its role in the up-regulation of the transcription of glucose transporter 214 genes, TG2 may confer other benefits to C. trachomatis. To identify TG2 targets in the 215 infectious process, HeLa cells were infected in the presence or absence of BP. Forty-eight 216 hours later the cells were lysed and biotinylated proteins were isolated on streptavidin-coated 217 beads, and identified by mass-spectrometry. Sixty-two proteins were found to be significantly 218 enriched in the infected cell lysates grown in the presence of BP (Table S1 ). Fibronectin, 219 galectin 3, RhoA, 40S ribosomal protein SA, immunoglobulin k chain C region and hemoglobin 220 beta were already identified as TG2 substrates ( Among the potential TG2 substrates we identified in C. trachomatis infected cells, the 226 enzyme glutamine:fructose-6-P amidotransferase (GFPT) caught our attention because it uses 227 fructose-6-P as a substrate, which is derived from glucose-6-P. Moreover, both isoforms of 228 the enzyme, GFPT1 (also called GFAT) and GFPT2, had been recovered from the proteomic 229 approach, making it a very strong hit. We first confirmed that GFPT was recovered in the 230 biotinylated fraction of cells infected with C. trachomatis in the presence of BP using anti-231
GFPT antibodies. The abundance of GFPT in the biotinylated fraction strongly decreased when 232 infection had been performed in the presence of the TG2 inhibitor CP4d, demonstrating that 233 incorporation of the biotinylated probe in GFPT depended on the activity of TG2 ( Fig. 4A ). 234
To further validate that GFPT is a novel substrate of TG2, purified TG2 and recombinant 235 human GFPT1 (rhGFPT1) were incubated for 3 h at 37 °C in the presence of BP as primary 236 amine donor. The incorporation of the biotinylated probe was analyzed by blotting with HRP-237 coupled streptavidin. The biotinylated probe was incorporated into rhGFPT1 in the presence 238
and not in the absence of TG2. Furthermore, chelation of Ca 2+ by EGTA inhibited the 239 incorporation of the probe, as expected for a reaction dependent on the transamidase activity 240 of TG2 ( Fig. 4B ). We concluded from these experiments that GFPT is a novel substrate of TG2 241 that becomes modified by the transamidase activity of the enzyme during C. trachomatis 242 infection. 243
In order to determine which glutamine residue(s) of GFPT1 was modified by TG2 in 244 vitro, we analyzed the products of the reaction by mass spectrometry. BP incorporation was 245 identified in ten glutamine residues (out of twenty-eight, Fig. 5C ), presumably because 246 promiscuous reactions occur in vitro. Among those, two glutamine residues were identified as 247 prone to modification by TG2 using bioinformatics tools designed to score the peptidic 248 environment favorable for TG2 activity, namely Q328 and Q546 (Keresztessy, Csosz et al., 249
2006, Sugimura, Hosono et al., 2006) . We thus generated a glutamine to asparagine point 250 mutant for each of these residues to minimize the impact on protein folding. As a control, we 251 also mutated Q58, another candidate target identified by mass spectrometry but not 252 surrounded by a consensus sequence for TG2. Purified recombinant proteins were incubated 253 with TG2 and BP for 30 min at 37 °C before stopping the reaction. BP incorporation was 254 significantly reduced only in the rhGFPT1 Q328N, indicating that the Q328 is a prominent 255 glutamine for modification by TG2 ( Fig. 4D ). 256
The fact that C. trachomatis produce their own GFPT prevented us from measuring the 257 consequence of TG2 activation on host GFPT activity in infected cells. However, ionomycin is 258 a widely used TG2 activator, as this Ca 2+ ionophore increases intracellular Ca 2+ concentration, 259 which opens TG2 in its active conformation. We thus measured GFPT activity in lysates of cells 260 treated or not with ionomycin, and analyzed the reaction products by high performance anion 261 exchange chromatography ( Fig. S5 ). We observed a three-fold increase in GFPT activity in cells 262 treated with ionomycin, indicating that GFPT modification by TG2 increases the activity of the 263 enzyme ( Fig. 4E ). 264 265
Modification of GFPT by TG2 enhances the hexosamine biosynthesis pathway 266
The reaction catalyzed by GFPT is the first and rate limiting step of the hexosamine 267 biosynthesis pathway (HBP, Fig. 5A ). The HBP leads to the formation of uridine 5'-diphospho- confirm that GFPT modification by TG2 increased its activity and thus hexosamine biosynthesis 276
we measured the level of O-GlcNAcylation in primary epithelial cells. We observed an increase 277
in O-GlcNAcylation in cells treated with ionomycin. This increase was dependent on TG2 278 activity since it was not observed in the presence of the TG2 inhibitor CP4d (Fig. 5B ) or in cells 279 in which tgm2 expression had been silenced using siRNA ( Fig. 5C ). Altogether these 280 experiments show that activation of TG2 transamidase activity enhances the HBP. 281 282
The increase in the hexosamine biosynthetic pathway is hijacked by the bacteria 283 Surprisingly, we did not observe an increase in O-GlcNAcylation in cells infected for 48 284 h by C. trachomatis (Fig. 6A ). Since O-GlcNAcylation directly depends on UDP-GlcNAc 285 concentration this observation suggests that UDP-GlcNAc levels in the cytoplasm are not 286 significantly increased in infected cells. We have previously demonstrated that C. trachomatis 287 co-opts SLC35D2, a host antiporter transporting UDP-GlcNAc, UDP-glucose and GDP-mannose 288 to import these metabolites into the vacuole in which the bacteria develop (Gehre et al., 289 2016). We reasoned that UDP-GlcNAc might not accumulate in the cytoplasm in infected cells 290 because it was relocated to the inclusion lumen. Supporting this hypothesis, we observed that 291 activation of TG2 by ionomycin elicited a lower increase in O-GlcNAcylation in infected cells 292 compared to non-infected cells, indicating that less free UDP-GlcNAc is available for O-293
GlcNAcylation in the infected host cytoplasm (Fig. 6B ). Importantly GFPT expression was 294 stable in all conditions, indicating that the decrease in O-GlcNAcylation in infected cells is not 295 due to lower GFPT expression ( Fig. 6A-B on bacterial size. The mass spectrometry data showed that both isoforms GFPT1 and GFPT2 304
were expressed in HeLa cells (Table S1 ). Comparison of the efficiency of siRNA designed to 305 target specifically one isoform showed that GFPT2 was hardly detectable and targeting GFPT1 306 was sufficient to strongly decrease GFPT expression ( Fig. 6C ). We thus lowered hexosamine 307 biosynthesis by treating cells with a siRNA against GFPT1 prior to infection, fixed the cells at 308 increasing time of infection and used flow cytometry to measure bacterial sizes. As expected, 309
the number of replicative bacteria increased with infection time (Fig. S5 ). Furthermore, it was 310 recently demonstrated that replicative bacteria gradually decrease in size over the course of 311 the developmental cycle (Lee, Enciso et al., 2017). We indeed observed a decrease in bacterial 312 diameter over a 20 to 26 hpi time course, thereby validating the use of flow cytometry to 313 measure the size of C. trachomatis ( Fig. S6 and 6D ). In cells treated with a siRNA against GFPT1 314 the mean bacterial diameter became significantly higher than in control cells 24 hpi ( Fig. 6D ). 315 We confirmed this result by measuring the diameter of bacteria on electron microscopy 316 pictures of cells infected for 30 h (Fig. S7 ). These kinetics fit well with our observation that TG2 317 activity increases between 24 and 48 hpi, when bacterial load is high, and access to nutrients 318 might become limiting (Rother, Gonzalez et al., 2018) . These observations support the 319 hypothesis that a product of the hexosamine biosynthesis pathway is captured by the 320 inclusion to support division. Consistent with a role for GFPT activity in sustaining bacterial 321 growth we observed a reduction in the number of bacteria per inclusion 24 h post infection in 322 the cells treated with siRNA against GFPT1, and the progeny collected was reduced 3-fold (Fig.  323 6E). Of note, silencing of GFPT1 had no incidence on bacterial entry and the initiation of 324 bacterial development, as the percentage of infected cells was identical to that in control cells 325 ( Fig. 6E ). Altogether, these data strongly support the hypothesis that the increase in 326 hexosamine biosynthesis by the host upon GFPT modification by TG2 is exploited by the 327 bacteria, in particular to assist bacterial division. 328 329 330 DISCUSSION 331 332 TG2 transamidase activity is very potent, and would be deleterious if not tightly 333 controlled. In basal conditions it is mostly turned off, and it is thought that under specific stress 334 conditions, the enzyme might be locally turned on and transamidate specific substrates. The 335 infection with C. trachomatis provided a unique physiological situation where the expression 336 and activity of the enzyme were increased over a relatively short period of time in a 337 physiological set-up. We took advantage of this observation to identify TG2 substrates. Among 338 the 62 candidates identified, we focused on the enzyme GFPT. We showed that GFPT 339 modification by TG2 increased its activity, resulting in higher hexosamine biosynthesis, a 340 process also fueled by the positive control exerted by TG2 on glucose transporters expression. 341
The product of the HBP, UDP-GlcNAc, is used for post-translational modification of proteins 342 by O-GlcNAcylation. Thus, our work uncovered an unsuspected link between TG2 343 transamidase activity and O-GlcNAcylation. This link was disrupted in infected cells because 344 the increase in hexosamine biosynthesis in the host was exploited by the bacteria, in particular 345
to assist their division. In conclusion, our work establishes TG2 as a key player in controlling 346 glucose-derived metabolic pathways in mammalian cells, themselves hijacked by C. 347
trachomatis to sustain their own metabolic needs (Fig. 6F ). 348
Several inflammatory conditions are associated with an increase in TG2 expression 349 (Eckert et al., 2014) . The promoter region of the TG2 gene (tgm2) contains, among others, 350 response elements to NF-kB and to the pro-inflammatory cytokine interleukin-6 (IL-6), 351
accounting for its increased transcription in inflammatory situations ( Treatment of cells with a potent inhibitor of TG2, CP4d, reduced progeny ten-fold in 361 primary epithelial cells (Fig. 2) . We have shown that the inhibition of TG2 activity had two 362 distinct effects on C. trachomatis developmental cycle. First, it reduced the ability for the 363 bacteria to enter the cells (Fig. S2 ). C. trachomatis use multiple receptors and appear to hijack 364 several entry pathways into epithelial cells (Ford, Nans et al., 2018) . The positive role played 365 by TG2 on bacterial entry, which could be exerted from its intracellular or extracellular 366 location, remains to be studied in future work. One attractive candidate mechanism is PDGFR 367 signaling, since it is implicated in C. trachomatis entry (Elwell, Ceesay et al., 2008) and it is 368 sensitive to TG2 activity (Nurminskaya, Beazley et al., 2014) . Second, the inclusion developed 369 slower in CP4d-treated culture, indicating that TG2 is necessary for optimal bacterial growth. 370 We discuss below the two mechanisms we uncovered that account for the link between TG2 371 activation and bacterial development, and place TG2 as a key regulator of bacterial access to 372 glucose and its derivative UDP-GlcNAc. 373 We have shown that TG2 is required for the increase in transcription of GLUT-1 and 374
GLUT-3 in infection in HeLa cells and in primary epithelial cells (Fig. 2) . A similar observation 375 was made in a mammary epithelial cell line (Kumar et al., 2014). In that case, it was shown 376 that TG2 constitutively activated NF-kB expression, promoting the expression of the hypoxia-377 inducible factor (HIF)-1a, which in turn promoted GLUT-1 transcription. A similar mechanism 378 may take place in the case of C. trachomatis infection, since HIF-1 is also increased (Sharma, 379 Machuy et al., 2011). Glucose is an essential metabolite for C. trachomatis development and 380
preventing the transcription of GLUT-1 and GLUT-3 by siRNA led to a two-fold decrease in 381 progeny in HeLa cells (Wang et al., 2017). This result shows that glucose import can become 382 limiting for bacterial growth, and thus that the control exerted by TG2 on the expression of 383 glucose transporters accounts, at least in part, for the need for this enzyme for optimal 384 bacterial growth. This conclusion is supported by our observation that glucose becomes 385 limiting faster for bacterial progeny in MEFs lacking TG2 than in wild-type cells. Thus, our study 386 places TG2 as a key regulator for glucose import in infected cells. 387
Our proteomic approach identified 62 candidate TG2 substrates in C. trachomatis 388 infection. Six of those were already known substrates of TG2, validating our analysis. We 389 further demonstrated that GFPT was a substrate of TG2 and identified Q328 as a prominent 390 transamidation site. The identification of which amine donor(s) are cross-linked to GFPT is left 391 to future investigations, as several small amines might serve as substrates, making 392 identification by mass spectrometry very challenging. We showed that GFPT activity was The role played by TG2 in viral or microbial infections is raising increasing interest. Like 409 in the case of C. trachomatis infection, genetic or pharmacological inhibition of TG2 led to a 410 marked reduction in Mycobacterium tuberculosis replicative capacity. However, the 411 mechanism involved might be different, since the data suggest that reduced replication in 412 macrophages lacking TG2 is due to the impairment of autophagy homeostasis ( For siRNA experiments, 50 000 cells were plated in a 24-well plate and immediately mixed 458
with Lipofectamine RNAiMAX (Invitrogen) following the manufacturer's recommendation, 459
using 10 nM of siRNA (Table S2 ). For RB size assessment, 300 000 cells were plated in a 6-well 460 plate. For electron microscopy experiments, 1.5 million cells were plated in a 25-cm 2 flask. For 461 GFPT1 activity assay, 1 million cells were plated in a 10-cm diameter dish. on the plasmid pET28-rhGFPT1-6His, with primers listed in Table S2, following the  472 manufacturer instructions, and transformed in E. coli Rosetta (DE3) GlmS::Tc. 473
One litre of culture in 2YT medium supplemented with tetracycline (8 µg.mL -1 , Sigma), 474 kanamycin (50 µg.mL -1 , Sigma), chloramphenicol (15 µg.mL -1 , Sigma) and glucosamine 475 (GlcNH2, 2 mg.mL -1 , Sigma) was incubated with agitation at 37 °C until OD600 reached 0.5. 476
Protein expression was induced by addition of 0.5 mM of isopropyl b-D-thiogalactopyranoside 477 (Sigma) at 25 °C for 24 h before being harvested. The cell pellets were resuspended in lysis 478 buffer (16.27 mM Na2HPO4 and 3.73 mM NaH2PO4 pH 7.5, 200 mM NaCl, 20 mM imidazole, 479 2 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP), 10 % glycerol, 1 mM fructose-6-P, 480
Roche EDTA-free protease inhibitor cocktail) and disrupted by sonication. The recombinant 481 protein was purified by incubation with Qiagen Ni-NTA agarose beads (Qiagen) for 1 h 482 followed by three washing steps with the lysis buffer before elution with lysis buffer 483 containing increasing concentrations of imidazole: 30 mM, 100 mM, 175 mM and finally 500 484 mM of imizadole. The fractions containing the protein were dialyzed against lysis buffer with 485 20 mM HEPES replacing the phosphate buffer before storage at -80 °C 486 487
TG2 activity assay 488 489
In vivo: Cells plated the day before (100 000 cells/well) were infected with C. trachomatis 490 serovar LGV L2 at a MOI of 1, and 0.5 µM biotin pentylamine (BP) (Thermo Fisher Scientific) 491
was added after 24 h. In some experiments, cells were pre-incubated for 2 h with 40 µM CP4d 492 or DMSO as control before addition of bacteria. CP4d inhibits the transamidase activity of TG2 493 (Ki = 174 nM) and favours its closed conformation (Caron et al., 2012) . For experiments with 494 ionomycin (Sigma), cells pre-treated with siRNA for 48 h or infected as described above for 24 495 h were treated with Ionomycin and 0.5 µM BP for 6 h. 496 At the end of the indicated incubation time, cells were lysed using 8 M urea buffer (30 mM  497 Tris, 150 mM NaCl, 8 M urea, 1 % SDS, pH=8.0) and samples subjected to Western Blot. 498 499
In vitro: 1 mU of transglutaminase from guinea pig liver (Sigma) was incubated at 37 °C for 15 500 min or 3 h with 5 µg of rhGFPT1, rhGFPT1 Q58N or rhGFPT1 Q328N and 1 mM of BP in 20 mM 501 HEPES buffer pH 7.5, 200 mM NaCl, 2 mM TCEP, 10 % glycerol, 1 mM fructose-6-phosphate, 502 10 mM CaCl2. The reaction was stopped by adding ethylene-bis(oxyethylenenitrilo)tetraacetic 503 acid (EGTA) at a final concentration of 20 mM and boiling the samples 5 min at 95 °C. 504 505
Streptavidin-precipitation of TG2 targets 506 507
Twenty million HeLa cells were seeded in a 163-cm 2 flask. One day later, the cells were 508 infected or not with C. trachomatis serovar LGV L2 at a MOI = 1. Two hours post infection 509 (hpi) the culture medium was changed and 40 µM CP4d or DMSO was added. BP was added 510 to the culture medium at 0.5 mM 24 h post treatment (infection or not) and cells were lysed 511 46 hpi directly in the well using 8 M urea buffer. DNA was disrupted by sonication and a 512 dialysis was performed against 2 M urea buffer (Tris 30 mM, NaCl 150 mM, 2 M urea, 1 % SDS, 513 pH=8.0). Samples were incubated overnight at 4 °C with streptavidin-agarose beads (Sigma). 514
After 3 washes with 2 M urea buffer and 3 washes with phosphate-buffered saline (PBS), 515
proteins precipitated on the beads were eluted using Laemmli's buffer containing 516 dithiothreitol (Sigma) boiled 5 min at 95 °C. Samples were then analyzed by Western blot or 517 by mass spectrometry. 518 519
SDS-PAGE and Western blot 520 521
Proteins were subjected to sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-522 PAGE) and transferred to a polyvinylidene difluoride (PVDF) membrane, which was blocked 523
with 1 x PBS containing 5 % bovine serum albumin (BSA, for biotin revelation only) or milk and 524 0.01 % Tween 20. The membranes were then immunoblotted with primary antibodies diluted 525
in 1 x PBS containing 5 % milk and 0.01 % Tween 20. For analyzing the TG2 activity assay, biotin 526 incorporation was revealed using streptavidin conjugated to HRP (Sigma). Primary antibodies 527 used in the western blots were the mouse clone 7D2 against TG2 (#ABIN1109303, Covalab), 528 rabbit anti-serum against GFPT (kindly given by Dr. C. Weigert, University of Tübingen, 529
Germany), mouse clone RL2 against O-GlcNAcylation (#MA1-072 Thermo Fisher Scientific) and 530 mouse clone AC-74 against β-actin (#A5441 Sigma). Secondary antibodies were anti-mouse-531 HRP (GE Healthcare) or anti-rabbit-HRP (Invitrogen) conjugated antibodies. Blots were 532 developed using the Western Lightning Chemiluminescence Reagent (GE Healthcare). 533 534
Ovarian cancer cohort and statistical analysis 535
Expression data for TGM2, GLUT-1 and GLUT-3 in 265 high grade serous ovarian cancers from 536
Edinburgh were available from previous transcriptomic studies of ovarian cancer (Hollis, 537 Churchman et al., 2019). Per-sample expression was calculated as the mean expression of 538 probe-sets informative for each gene. Expression comparisons were performed using 539
Spearman's rank correlation test. 540 541
Mass Spectrometry 542 543
In solution protein digestion: Samples were prepared in triplicate. For streptavidin-544 precipitation of TG2 targets samples, tryptic digestion was performed by enhanced filter-545 aided sample preparation. All steps were done in-filter. Briefly, samples were reduced (50 mM 546 TCEP, 30 minutes at room temperature) and alkylated (50 mM iodoacetamide, 1 h at room 547 temperature in the dark). Then, proteins were incubated overnight at 37 °C with 500bng 548 trypsin (Trypsin Gold Mass Spectrometry Grade, Promega). Peptides were recovered by 549 centrifugation. 550
After TG2/GFPT1 reactions in vitro samples were diluted in a large excess of 8 M urea / 100 551 mM Tris HCl pH 8.5 buffer and then, as previously described, reduced (5 mM TCEP, 30 minutes 552 at room temperature) and alkylated (10 mM iodoacetamide, 30 minutes at room temperature 553 in the dark). Proteins were first digested for 5 h at 37 °C with 500 ng rLys-C Mass Spec Grade 554 (Promega, Madison, WI, USA) before being diluted 4-fold with 100 mM Tris HCl pH 8.5 to reach 555 a concentration below 2 M urea. Samples were then incubated overnight at 37 °C with 500 ng 556
Sequencing Grade Modified Trypsin (Promega, Madison, WI, USA). To achieve the complete 557 digestion of the peptides, a second incubation with the same amount of trypsin (5 h at 37 °C) 558 was performed. Digestion was stopped by adding formic acid to 5 % final concentration and 559 peptides were desalted and concentrated on Sep-Pak C18SPE cartridge (Waters, Milford, MA, 560 USA) according to manufacturer instructions. 561 562
Mass spectrometry analysis: Tryptic peptides were analyzed on a Q Exactive Plus instrument 563
(Thermo Fisher Scientific, Bremen) coupled with an EASY nLC 1 000 or 1 200 chromatography 564 system (Thermo Fisher Scientific, Bremen). Sample was loaded on an in-house packed 50 cm 565 nano-HPLC column (75 μm inner diameter) with C18 resin (1.9 μm particles, 100 Å pore size, 566
Reprosil-Pur Basic C18-HD resin, Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) and 567 equilibrated in 98 % solvent A (H2O, 0.1 % FA) and 2 % solvent B (ACN, 0.1 % FA). 120 or 180 568 min gradient of solvent B at 250 nL.min -1 flow rates were applied to separated peptides. The 569 instrument method for the Q Exactive Plus was set up in DDA mode (Data Dependent 570 Acquisition). After a survey scan in the Orbitrap (resolution 70 000), the 10 most intense 571 precursor ions were selected for HCD fragmentation with a normalized collision energy set up 572 to 28. Charge state screening was enabled, and precursors with unknown charge state or a 573 charge state of 1 and > 7 were excluded. to 20 ppm for the first search then 6 ppm for the main search and 10 ppm for the MS/MS. 586
Maximum peptide charge was set to seven and five amino acids were required as minimum 587 peptide length. The "match between runs" feature was applied between replicates with a 588 maximal retention time window of 2 or 0.7 min. One unique peptide to the protein group was 589 required for the protein identification. A false discovery rate (FDR) cutoff of 1 % was applied 590
at the peptide and protein levels. 591 592
Data analysis: To validate the identification of the BP on the glutamine of modified peptides, 593 spectra were manually inspected (or fragment assignments). 594
For the global quantification, output files from MaxQuant were used for protein 595 quantification. Quantification was performed using the XIC-based LFQ algorithm with the Fast 596 LFQ mode as described previously (Cox, Hein et al., 2014) . Unique and razor peptides, included 597 modified peptides, with at least 2 ratio count were accepted for quantification. 598
For pairwise comparisons, proteins identified in the reverse and contaminant databases and 599 proteins only identified by site were first discarded from the list. Then, proteins exhibiting 600 fewer than 2 LFQ values in at least one condition were discarded from the list to avoid 601 misidentified proteins. ). An adaptive Benjamini-Hochberg procedure was applied on the resulting p-values 611 thanks to the function adjust.p of R package cp4p using the robust method of Pounds and 612 Cheng to estimate the proportion of true null hypotheses among the set of statistical tests 613 (Pounds & Cheng, 2006) . The proteins associated to an adjusted p-value inferior to an FDR 614 level of 1% have been considered as significantly differentially abundant proteins. 615
616
Adhesion assay 617 618
Adhesion assays were performed as described previously (Vromman et al., 2014) . In brief, 619
MEFs cells plated in 24-well plate the day before (100 000 cells/well) were pre-cooled 30 min 620 at 4 °C and then were incubated for 4 h at 4 °C with L2 IncD GFP bacteria at a MOI = 10, sonicated 621 prior to infection in order to disrupt bacterial aggregates. Then cells were washed gently with 622 PBS and detached using 0.5 mM EDTA in PBS. Samples were fixed 30 min in 2 % PFA, washed 623 with PBS and analyzed using flow cytometry. 624 625
Bacterial entry assessment 626 627
Entry experiments were performed as described previously (Vromman et al., 2014) . In brief, 628
MEFs cells plated on coverslips in 24-well plate the day before (100 000 cells/well) were pre-629 cooled 30 min at 4 °C and then incubated for 45 min at 4 °C with L2 IncD GFP bacteria at a MOI 630 = 10, sonicated prior to infection in order to disrupt bacterial aggregates. Then pre-warmed 631 medium was added and coverslips were incubated at 37 °C before being fixed at different time 632 points in 4 % PFA for 20 min. Extracellular bacteria were stained with a mouse anti-MOMP-633 LPS (Argene # 11-114) antibody followed with Cy5-conjugated anti-mouse (Amersham 634
Biosciences) secondary antibody. The dilutions were made in PBS containing 3 % of BSA. DNA 635 was stained using 0.5 µg.mL -1 of Hoechst 33342 (Thermo Fisher Scientific) added in the 636 secondary antibody solution. Images were acquired on an Axio observer Z1 microscope 637 equipped with an ApoTomemodule (Zeiss, Germany) and a 63× Apochromat lens. Images were 638 taken with an ORCAflash4.OLT camera (Hamamatsu, Japan) using the software Zen. 639 640
Progeny assay 641 642
For glucose privation tests on MEFs cells, 140 000 cells per well were seeded in a glucose-free 643 DMEM (Invitrogen) supplemented with 10 % FBS. The following day, the medium was replaced 644
with glucose-free DMEM supplemented with 10 % FBS and the indicated concentration of 645 glucose (Sigma). The next day cells were infected with L2 IncD GFP bacteria at a MOI = 0.2. 646
For progeny assays on HeLa cells, primary cells or MEFs cells, 100 000 cells were seeded in a 647
24-well plate. The next day cells were pre-treated with CP4d (or DMSO) for 2 h and infected 648 with L2 IncD GFP bacteria at a MOI = 0.15. Cells treated with siRNA for 48 h were directly infected 649 with L2 IncD GFP bacteria at a MOI = 0.2. Thirty hpi, cells were detached and fixed in 2 % PFA in 650 PBS prior to flow cytometry analysis in order to evaluate the first round of infection. In 651 duplicate wells, cells were detached, lysed using glass beads and the supernatant was used to 652 infect new untreated cells (or WT cells in the case of MEFs) plated the day before (100 000 653 cells/well in a 24-well plate), in serial dilution. The next day, 3 wells per condition with an 654 infection lower than 30 % (checked by microscopy) were detached and fixed as described 655 above, before analysis by flow cytometry and determination of the bacterial titer. Acquisition 656 was performed using a CytoFLEX S (Beckman Coulter) and 50 000 events per sample were 657 acquired and then analyzed using FlowJo (version 10.0.7). 658 659
Infection in mice 660 661
Female TG2 -/and TG2 +/+ KO mice were kindly provided by Dr. C. Papista (INSERM UMR970, 662
Centre de Recherche Cardiovasculaire, Paris) and maintained in the animal facility of the 663 Institut Pasteur, Paris. All animals are treated with 2.5 mg of medroxyprogesterone (Depo-664 purified C. trachomatis elementary bodies (i.e. the infectious non-replicative form of the 713 bacterium) and non-infected cells prepared the same way were used to gate successively for 714 particles of equal size or smaller than E. coli (thereby excluding non-broken cells), larger than 715 elementary bodies (thereby excluding non-dividing bacteria), and with positive green 716 fluorescence (thereby excluding cell debris proteins were transferred to a membrane and BP incorporation was revealed with HRP-925 conjugated streptavidin. BP incorporation is enhanced in infected samples, and is inhibited by 926
CP4d. The two main bands present in all samples correspond to naturally biotinylated host 927 proteins. After blotting the membrane was stained with Coomassie blue to control for equal 928
loading. B -Same as in A, except that where indicated 250 µM doxycycline (doxy, left) or 7 929
µM cycloheximide (CHX, right) were added 24 h or 2 hpi, respectively. C -Whole cell lysates 930
were prepared with TG2 +/+ and TG2 -/-MEFs infected or not for 48 h with C. trachomatis L2 in 931 the presence or not of BP, and analyzed as in A. D -Western blot with anti-TG2 antibodies on 932 total cell lysates infected or not with C. trachomatis L2. E -Cells were infected with C. 933 trachomatis L2 (MOI=1) for 24 or 48 h. Where indicated, 40 µM CP4d was added 2 hpi. tgm2 934 transcripts were measured by real-time RT-PCR and normalized to actin transcripts following 935
the DDCt method. The data are presented as relative mRNA levels compared to uninfected 936 cells and shown as the mean ± SD. Each experiment was performed in duplicate and repeated 937 at four times. The asterisk indicates significantly different values (P < 0.05, Student's ratio-938 paired t-test). 939 940 Figure 2 . TG2 activity is needed for optimal C. trachomatis developmental and enhances 941 hydrosalpinx upon C. muridarum infection in mice A -HeLa cells were pre-treated with the 942 indicated concentrations of CP4d (or DMSO alone) for 2 h before being infected with L2 incD GFP 943 at MOI=0.15. Thirty hours later the cells were disrupted and bacterial titers (IFU=inclusion 944 forming unit) were determined by re-infecting fresh HeLa cells as described in the methods. 945
The mean ± SD of three independent experiments are shown. B -Same as in A except that C. 946 trachomatis serovar L2 (left) or D (right) were grown in primary cells isolated from fallopian 947 tubes. For serovar D, IFU were determined 48 hpi. C -HeLa cells were pre-treated with the 948 indicated concentrations of CP4d (or DMSO alone) for 2 h before being infected with L2 incD GFP 949 at MOI=0.15. Thirty hours later the cells were fixed and analyzed by flow cytometry. The 950 percentage of infected cells (left) and the mean fluorescence of the infected population (right) 951 are shown for three independent experiments. A representative field for each condition is 952
shown, bar = 10 µM. D -Primary epithelial cells isolated from fallopian tubes were pre-treated 953 with the indicated concentrations of CP4d (or DMSO alone) for 2 h before being infected with 954 C. trachomatis serovar L2 (left) or D (right). Twenty-four hours later the cells were fixed, 955 bacteria were stained using FITC-labeled anti-Chlamydia-LPS antibodies, and the size of the 956 inclusions manually determined using ImageJ, on twenty inclusions per experiment. Asterisks 957 indicate two significantly different values (*: P < 0.05; **: P < 0.01, Student's paired t-test). E 958 -Mice were infected intravaginally with 10 5 IFU of C. muridarum. Twenty-five days later the 959 mice were sacrificed and the upper genital tract, from the uterine horn to the oviduct, was 960 collected. The right part was used for bacterial burden assessment (top left). The left part was 961 rinsed with PBS and observed with a binocular magnifier (right) to determine the hydrosalpinx 962 score (bottom left). Asterisk indicates significantly different values (P < 0.05, Student's 963 unpaired t-test). 964 965 Figure 3 . TG2 controls glucose import A -MEFs were grown for 24 h culture medium 966 complemented with the indicated concentration of glucose before being infected with L2 967
